Real-world efficacy and safety profile of sulthiame treatment in drug-resistant childhood epilepsy.
OBJECTIVE Sulthiame (STM) is a potent carbonic anhydrase inhibitor primarily used in focal epilepsy syndromes; however, clinical data regarding its efficacy and safety in broader drug-resistant childhood epilepsy remain limited. This study aimed to evaluate the clinical efficacy, electroencephalographic response, and s...